XML 68 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation - Stock Option Activity (Details) (2007 Amended and Restated Long-term Incentive Plan, USD $)
In Thousands, except Share data, unless otherwise specified
0 Months Ended 6 Months Ended 12 Months Ended
Nov. 11, 2013
Dec. 31, 2013
Dec. 31, 2012
Jun. 30, 2013
Non-qualified Stock Options with Time-based Vesting (NQO) [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options   535,754   557,427
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1,927      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period   (8,765)    
Number of Stock Options, Cancelled/Forfeited   (14,835)    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]        
Weighted Average Exercise Price, Beginning balance   $ 12.81    
Weighted Average Exercise Price, Granted $ 18.68      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price   $ 14.24    
Weighted Average Exercise Price, Ending balance   $ 14.12   $ 12.81
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted Average Grant Date Fair Value, Beginning balance   $ 5.44    
Weighted average fair value of PNQs   $ 9.17 $ 5.54  
ShareBased Compensation Arrangement By ShareBased Payment Award,Options, Exercises In Period, Weighted Average Grant Date Fair Value   $ 6.32    
Weighted Average Grant Date Fair Value, Cancelled/Forfeited   $ 6.05    
Weighted Average Grant Date Fair Value, Ending balance   $ 6.27   $ 5.44
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value [Roll Forward]        
Aggregate Intrinsic Value, Beginning balance   $ 5,874 [1]   $ 1,620 [1]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value   0 [1]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Cancellations/Forfeitures in Period, Total Intrinsic Value   64 [1]    
Aggregate Intrinsic Value, Ending balance   5,874 [1]   1,620 [1]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Weighted Average Remaining Life, Beginning balance   5 years 1 month 6 days   5 years 1 month 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Remaining Contractual Term   7 years 0 months 0 days    
Weighted Average Remaining Life, Ending balance   5 years 1 month 6 days   5 years 1 month 6 days
Options, Vested and exercisable, Outstanding   315,574    
Options, Vested and exercisable, Weighted Average Exercise Price   $ 14.30    
Options, Vested and exercisable, Weighted Average Grant Date Fair Value   $ 5.75    
Options, Vested and exercisable, Weighted Average Remaining Contractual Term   4 years 0 months 0 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value   2,828 [1]    
Options, Vested and expected to vest, Outstanding   518,645    
Options, Vested and expected to vest, Weighted Average Exercise Price   $ 12.74    
Options, Vested and expected to vest, Weighted Average Grant Date Fair Value   $ 6.19    
Options, Vested and expected to vest, Exercisable, Weighted Average Remaining Life   4 years 8 months 12 days    
Non-qualified Stock Options with Performance-based and Time-based Vesting (PNQ) [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]        
Number of Stock Options, Beginning balance   0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   107,035    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period   0    
Number of Stock Options, Cancelled/Forfeited   0    
Number of Stock Options, Ending balance   107,035    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]        
Weighted Average Exercise Price, Beginning balance   $ 0.00    
Weighted Average Exercise Price, Granted   $ 21.33    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price   $ 0.00    
Weighted Average Exercise Price, Cancelled/Forfeited   $ 0.00    
Weighted Average Exercise Price, Ending balance   $ 21.33    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted Average Grant Date Fair Value, Beginning balance   $ 0.00    
Weighted average fair value of PNQs   $ 10.52    
ShareBased Compensation Arrangement By ShareBased Payment Award,Options, Exercises In Period, Weighted Average Grant Date Fair Value   $ 0.00    
Weighted Average Grant Date Fair Value, Cancelled/Forfeited   $ 0.00    
Weighted Average Grant Date Fair Value, Ending balance   $ 10.52    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value [Roll Forward]        
Aggregate Intrinsic Value, Beginning balance   207 [1]   0 [2]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value   0 [2]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Cancellations/Forfeitures in Period, Total Intrinsic Value   0 [1]    
Aggregate Intrinsic Value, Ending balance   207 [1]   0 [2]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Weighted Average Remaining Life, Beginning balance   7 years 0 months 0 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Remaining Contractual Term   7 years 0 months 0 days    
Weighted Average Remaining Life, Ending balance   7 years 0 months 0 days    
Options, Vested and exercisable, Outstanding   0    
Options, Vested and exercisable, Weighted Average Exercise Price   $ 0.00    
Options, Vested and exercisable, Weighted Average Grant Date Fair Value   $ 0.00    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value   0 [1]    
Options, Vested and expected to vest, Outstanding   91,979    
Options, Vested and expected to vest, Weighted Average Exercise Price   $ 21.33    
Options, Vested and expected to vest, Weighted Average Grant Date Fair Value   $ 10.52    
Options, Vested and expected to vest, Exercisable, Weighted Average Remaining Life   7 years 0 months 0 days    
Options, Vested and expected to vest, Aggregate Intrinsic Value   $ 178 [1]    
[1] (1) Aggregate intrinsic value represents the total pretax intrinsic value, based on the Company’s closing stock price of $23.26 at December 31, 2013, representing the last trading day of the fiscal quarter ended December 31, 2013, which would have been received by NQO holders had all award holders exercised their NQOs that were in-the-money as of that date.
[2] These amounts represent the estimated portion of the net (gain) loss and net prior service cost (credit) remaining in AOCI that is expected to be recognized as a component of net periodic benefit cost over the current fiscal year.